TECH NEWS
InSilico is on a mission: Be no. 1 in China, create ‘God-like' drug with AI
The pharma company, first to use generative AI to develop a drug that reached clinical trials, is betting longevity treatments will fuel next phase of growth. AI drug-discovery firm InSilico has been developing treatments for cancer, Parkinson’s and pulmonary fibrosis. Next up: a “God-like” drug that extends your lifespan.